Abstract: The present invention discloses a method, device and application of solid-state phase change heat storage and heat release of barocaloric materials based on glassy-crystals and active control, which belongs to the technical field of solid-state phase change energy storage. A glassy-crystal phase is an intermediate metastable state formed in the change process from a high temperature plastic-crystal phase to an ordered crystal phase, which can be obtained by cooling the high temperature plastic-crystal disordered state of the barocaloric materials quickly. Rapid cooling makes the high temperature disordered state of the material supercooled and frozen, thereby avoiding the full oriented order that generally occurs at low temperature. The material is applied with a small pressure, which can achieve the change from the glassy-crystal phase to the ordered crystal phase, thereby achieving heat release.

Abstract: Disclosed is an application of a magnetic carboxyl-functionalized covalent organic framework composite as a magnetic solid-phase extraction adsorbent. The preparation method for this composite comprises the following steps: (1) firstly, taking dopamine hydrochloride as a coordinating stabilizer, and synthesizing surface-aminated magnetic iron oxide particles by coprecipitating iron (III) chloride and iron (II) chloride; and (2) then activating the surface-aminated magnetic iron oxide particles, and performing covalent cross-linking on the surfaces of the aminated magnetic iron oxide particles by taking 1, 3, 5-triformylphloroglucinol (Tp) and 4, 4?-diamino-biphenyl-2, 2?-dicarboxylic acid as building blocks, acting under the reversible catalytic action of acetic acid and using a solvothermal synthesis method, so as to prepare the magnetic carboxyl-functionalized covalent organic framework composite.

Abstract: The present invention provides a method for treating cancer patients accompanied by pain by combining an AKR1C3-activated anticancer prodrug compound with an analgesic drug, a pharmaceutical use, a drug combination and a pharmaceutical formulation thereof, which provides a reasonable alternative for clinical cancer treatment. In particular, the combination of AST-3424 and non-steroidal analgesic drug can achieve the effect of simultaneously treating cancer and relieving pain.

Abstract: An array substrate, a driving method thereof, and a display device. In the array substrate, rows of sub-pixels include groups of sub-pixels, each group of sub-pixels includes part of the rows of sub-pixels, and charging times of the part of the rows of sub-pixels are overlapped. A charging time of the second part of the plurality of rows of sub-pixels is longer than a charging time of the first part of the plurality of rows of sub-pixels. During a first time period, a same data signal is written into the first part of the plurality of rows of sub-pixels and the second part of the plurality of rows of sub-pixels, and during a second time period, a data signal written into the second part of the plurality of rows of sub-pixels is at least partially the same as the data signal written during the first time period.

Abstract: A car lock device and an elevator system. The car lock device is used for the elevator system including an elevator car and guide rails, the car lock device includes a locking unit fixedly connected to the elevator car and at least two paired limiting units fixed on the guide rails, the locking unit including a rotatable locking rod, and the locking unit having a first rotation position and a second rotation position, in the first rotation position, the locking rod is decoupled from the guide rails to ensure the normal operation state of the elevator car, and in the second rotation position, the locking rod can interfere with the paired limiting units and be restricted between the paired limiting units, so that the elevator car cannot operate normally.

Abstract: A front fascia for a vehicle including a camera assembly; a first panel defining a through-hole configured for receipt of the camera assembly, a perimeter of the through-hole having a plurality of retention features configured to support and orient the camera assembly relative to the through-hole; and a second panel including a seat configured for receipt of the camera assembly, wherein the first panel includes a plurality of hollow protrusions located proximate the through-hole configured to mate with a plurality of projections formed on the second panel; and the camera assembly is sandwiched and secured between the first panel and the second panel when the plurality of projections are mated with the plurality of hollow protrusions.

Abstract: The present invention relates to Compounds of Formula I: and pharmaceutically acceptable salts or prodrug thereof, wherein R1, R2, R3, R4 and A are as defined herein. The present invention also relates to compositions comprising at least one compound of Formula I, and methods of using the compounds of Formula I for treating or preventing HIV infection in a subject.

Abstract: Embodiments of the present disclosure provide a scheduling method and device for a cloud native orchestration and scheduling system and a storage medium. A target judgment rule plugin is determined from multiple preset judgment rule plugins included in a preset judgment rule plugin set and loaded into a scheduler of the cloud native orchestration and scheduling system; whether any instance on any node in the cloud native orchestration and scheduling system is allowed to be preempted by a to-be-deployed instance is sequentially judged by using the target judgment rule plugin for the to-be-deployed instance; a candidate to-be-preempted instance on a candidate to-be-preempted node is determined; candidate to-be-preempted nodes are sorted by using a preset comparison plugin in the scheduler to determine a target to-be-preempted node, and the to-be-deployed instance is controlled to preempt the candidate to-be-preempted instance on the target to-be-preempted node.

Abstract: The present disclosure provides a cluster-based scheduling method, a medium and an electronic device, the method includes: in response to a current scheduling, obtaining a historical scheduling snapshot generated in a previous scheduling and reading a global timing value corresponding to a cluster during the previous scheduling from the historical scheduling snapshot, where the global timing value is a latest change timing of a node in the cluster during the previous scheduling recorded in chronological order; reading a respective timing value corresponding to each node in the cluster during the current scheduling from a scheduling cache and selecting, using the global timing value as a reference, a target node whose timing value is later than the global timing value in chronological order; and updating the historical scheduling snapshot based on node information of the target node to obtain a scheduling snapshot of the current scheduling.

Abstract: In a packet transmission in an interconnection network, a first device and a second device are connected using a queue pair (QP). The transmission includes: a transmit device locally storing a first mapping table and a send queue. The first mapping table stores an identifier of a packet received by a receive device, and the send queue stores a to-be-sent packet. When the to-be-sent first packet is a packet needing to be sent in order, the transmit device may determine, based on a packet identifier stored in the first mapping table, whether a previous packet of the first packet has been received by the peer end. Sending of a subsequent packet not needing to be sent in order may not be blocked, and bandwidth of the interconnection network can be fully utilized.

Abstract: A packet transmission method includes a first device that receives a packet that is of a first application and that is to be sent to a second device; the first device determines whether a transport TP connection is established between the transport layer of the first device and a transport layer of the second device; and when at least one TP connection has been established between the transport layer of the first device and the transport layer of the second device, the first device determines that the at least one TP connection is used to transmit the packet of the first application, where the at least one TP connection is a TP connection established by the first device to transmit a packet of a second application.

Abstract: The present invention relates to a hair removal device and a Peltier cooler. The hair removal device comprises a hair removal head, a light source assembly, a power supply unit, and a control circuit board; the power supply unit supplies power to the light source assembly, and the control circuit board controls the light source assembly to generate pulsed light; a transparent medium body is mounted on the hair removal work head to serve as a hair removal work surface coming into contact with skin so as to form a transparent medium hair removal work surface. The Peltier cooler comprises a semiconductor pillar layer, and a hot surface and a cold surface at two ends of the semiconductor galvanic couple layers; the cold surface is a transparent crystal so as to form a transparent crystal cold surface.

Abstract: This application relates to a communication method based on a virtual role interaction interface, including: displaying, in a virtual role interaction application, a virtual role interaction interface comprising a target virtual role identifier; receiving a user operation directed to the target virtual role identifier; displaying, in response to the user operation, a message input interface configured to obtain a session message associated with the virtual role interaction interface; determining an instant messaging user account corresponding to the target virtual role identifier; and transmitting, after the session message is inputted in the message input interface, the session message and displaying the session message on an instant messaging application to the instant messaging user account corresponding to the target virtual role identifier.

Abstract: The present application discloses a method for detecting an abnormity in a ray source in a CT system, comprising obtaining scanning data obtained from at least two scans that are performed by a medical device, the medical device including a ray source configured to generate a plurality of rays and a detector configured to detect the plurality of rays; determining, based on a difference of the scanning data, a status characteristic index of the ray source; and determining whether abnormity exists in the ray source based on the status characteristic index.

Abstract: A battery securing component configured to be mounted on a vehicle body is provided. A battery is vertically disposed on the vehicle body. The battery securing component includes: a lifting column vertically arranged on a side of the battery, and a lower end of the lifting column being threadedly connected to the vehicle body to cause the lifting column to be capable of moving up and down by rotating; a pressing sleeve rotatably sleeved on the lifting column and configured to be moved up and down in synchronization with the lifting column; a pressing arm being formed on the pressing sleeve by protruding toward the battery, higher than the battery) and an elastic engaging structure configured to drive the pressing sleeve to rotate in synchronization with the lifting column, and arranged between the pressing sleeve and the lifting column.

Abstract: The present invention aims to provide an application of an ammonium ion-containing halogen compound in solid-state refrigeration and a novel efficient solid-state refrigeration method driven by a pressure. The ammonium ion-containing halogen compound is characterized in that phase change can be induced with only a small pressure, resulting in a huge barocaloric effect, and the unit pressure thereof drives the phase-change temperature displacement as high as 0.81 Kmin?1. Ammonium iodide produces 89.07 J kg?1K?1 isothermal entropy change under a pressure of 20 MPa; and the use of this material for a refrigeration cycle is far superior to other material systems having a barocaloric effect.

Abstract: The present disclosure provides antibody drug conjugate platforms comprising a conjugator assembly component, and antibody drug conjugates comprising platform-derived linker-payloads and antibodies or antigen-binding fragments thereof. In some embodiments, an antibody drug conjugate is of the following formula or a pharmaceutically acceptable salt, tautomer, solvate, or stereoisomer thereof, wherein values for the variables (e.g., BA, U, V, A, a?, W, w?, Y, y?, PA, x) are as described herein.